Bénédicte Deau

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi et al. · Nature Medicine · 2022 · 343 citations · Full text

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial

Anne‐Ségolène Cottereau, Annibale Versari, Annika Loft et al. · Blood · 2018 · 176 citations · Full text

Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with <scp>non‐Hodgkin</scp> lymphoma treated with B‐cell depleting immunotherapy

Rémy Duléry, Sylvain Lamure, Marc Delord et al. · American Journal of Hematology · 2021 · 156 citations · Full text

Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

Cédric Rossi, Julia Gilhodes, Marie Maerevoet et al. · American Journal of Hematology · 2018 · 116 citations · Full text

β-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation

Laure Meyer, Bénédicte Deau, Hana Forejtníková et al. · Blood · 2007 · 72 citations